• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

抑制骨吸收可减轻骨重建率高的小鼠骨关节炎。

Inhibition of bone resorption blunts osteoarthritis in mice with high bone remodelling.

机构信息

INSERM U606, Centre Viggo Petersen and Université Paris-Diderot Paris 7, Hôpital Lariboisière, 2 rue Ambroise Paré, Paris 75010, France.

出版信息

Ann Rheum Dis. 2010 Aug;69(8):1533-8. doi: 10.1136/ard.2009.124586. Epub 2010 Jun 4.

DOI:10.1136/ard.2009.124586
PMID:20525838
Abstract

BACKGROUND

Osteoarthritis (OA) is characterised by cartilage degradation and bone lesions. Subchondral bone may be involved in the pathogenesis of cartilage matrix breakdown.

OBJECTIVE

To assess the role of bone remodelling in OA by studying the effect of bisphosphonate on OA development in mice with high bone remodelling.

METHODS

Mice overexpressing Runx2 (Runx2-Tg) under the control of collagen type I that displayed high bone remodelling were used. Joint instability was performed by partial medial meniscectomy to induce OA.

RESULTS

Six weeks after surgery, tibial cartilage of Runx2-Tg mice displayed an increased number of ADAMTS-4- and ADAMTS-5-expressing chondrocytes compared with controls (p<0.05). This increase was higher in Runx2-Tg mice than in wild-type mice, although their OA score did not differ (2.5+/-0.6 vs 2.4+/-0.2, P=NS). Pamidronate reduced the OA score in Runx2-Tg mice but not in wild-type littermates (1.2+/-0.5 vs 2.7+/-0.4; p<0.05) despite the reduction of bone resorption and of the expression of cartilage proteases in both genotypes.

CONCLUSIONS

These findings support the hypothesis that the level of bone resorption influences cartilage metabolism and that inhibition might prevent the progression of OA. Targeting bone resorption might therefore provide an approach to the treatment of high bone resorbing forms of OA.

摘要

背景

骨关节炎(OA)的特征是软骨降解和骨损伤。软骨下骨可能参与了软骨基质破坏的发病机制。

目的

通过研究双膦酸盐对高骨重塑小鼠 OA 发展的影响,评估骨重塑在 OA 中的作用。

方法

使用在 I 型胶原控制下过表达 Runx2 的小鼠(Runx2-Tg),其表现出高骨重塑。通过部分内侧半月板切除术导致关节不稳定以诱导 OA。

结果

手术后 6 周,Runx2-Tg 小鼠的胫骨软骨中 ADAMTS-4 和 ADAMTS-5 表达的软骨细胞数量增加,与对照组相比(p<0.05)。尽管它们的 OA 评分没有差异(2.5+/-0.6 与 2.4+/-0.2,P=NS),但这种增加在 Runx2-Tg 小鼠中比在野生型小鼠中更高。帕米膦酸盐降低了 Runx2-Tg 小鼠的 OA 评分,但对野生型同窝小鼠没有影响(1.2+/-0.5 与 2.7+/-0.4;p<0.05),尽管两种基因型的骨吸收和软骨蛋白酶表达均减少。

结论

这些发现支持这样一种假设,即骨吸收水平影响软骨代谢,抑制可能会阻止 OA 的进展。因此,靶向骨吸收可能是治疗高骨吸收型 OA 的一种方法。

相似文献

1
Inhibition of bone resorption blunts osteoarthritis in mice with high bone remodelling.抑制骨吸收可减轻骨重建率高的小鼠骨关节炎。
Ann Rheum Dis. 2010 Aug;69(8):1533-8. doi: 10.1136/ard.2009.124586. Epub 2010 Jun 4.
2
Targeting bone alleviates osteoarthritis in osteopenic mice and modulates cartilage catabolism.靶向骨骼可减轻骨质疏松症小鼠的骨关节炎并调节软骨分解代谢。
PLoS One. 2012;7(3):e33543. doi: 10.1371/journal.pone.0033543. Epub 2012 Mar 14.
3
Molecular changes in articular cartilage and subchondral bone in the rat anterior cruciate ligament transection and meniscectomized models of osteoarthritis.骨关节炎大鼠前交叉韧带切断和半月板切除术模型中关节软骨和软骨下骨的分子变化。
BMC Musculoskelet Disord. 2011 Aug 24;12:197. doi: 10.1186/1471-2474-12-197.
4
Deletion of Runx2 in Articular Chondrocytes Decelerates the Progression of DMM-Induced Osteoarthritis in Adult Mice.软骨细胞中 Runx2 的缺失可延缓成年小鼠 DMM 诱导的骨关节炎的进展。
Sci Rep. 2017 May 24;7(1):2371. doi: 10.1038/s41598-017-02490-w.
5
Attenuation of cartilage degeneration by calcitonin gene-related paptide receptor antagonist via inhibition of subchondral bone sclerosis in osteoarthritis mice.降钙素基因相关肽受体拮抗剂通过抑制骨关节炎小鼠软骨下骨硬化减轻软骨退变
J Orthop Res. 2016 Jul;34(7):1177-84. doi: 10.1002/jor.23132. Epub 2016 Jan 12.
6
Halofuginone attenuates osteoarthritis by inhibition of TGF-β activity and H-type vessel formation in subchondral bone.常山酮通过抑制转化生长因子-β活性和软骨下骨中H型血管形成来减轻骨关节炎。
Ann Rheum Dis. 2016 Sep;75(9):1714-21. doi: 10.1136/annrheumdis-2015-207923. Epub 2015 Oct 15.
7
Enhancement of the synthesis of n-3 PUFAs in fat-1 transgenic mice inhibits mTORC1 signalling and delays surgically induced osteoarthritis in comparison with wild-type mice.与野生型小鼠相比,Fat-1 转基因小鼠中 n-3PUFAs 的合成增强可抑制 mTORC1 信号通路,从而延缓手术诱导的骨关节炎。
Ann Rheum Dis. 2014 Sep;73(9):1719-27. doi: 10.1136/annrheumdis-2013-203231. Epub 2013 Jul 12.
8
Dkk-1-mediated inhibition of Wnt signaling in bone ameliorates osteoarthritis in mice.DKK-1 介导的 Wnt 信号抑制可改善骨关节炎小鼠的骨关节炎。
Arthritis Rheumatol. 2014 Nov;66(11):3028-39. doi: 10.1002/art.38799.
9
Strontium ranelate reduces cartilage degeneration and subchondral bone remodeling in rat osteoarthritis model.雷奈酸锶可减少大鼠骨关节炎模型中的软骨退变和软骨下骨重塑。
Acta Pharmacol Sin. 2013 Mar;34(3):393-402. doi: 10.1038/aps.2012.167. Epub 2013 Jan 21.
10
Inhibition of osteoclasts prevents cartilage loss and pain in a rat model of degenerative joint disease.抑制破骨细胞可预防退行性关节疾病大鼠模型中的软骨丢失和疼痛。
Osteoarthritis Cartilage. 2010 Oct;18(10):1319-28. doi: 10.1016/j.joca.2010.06.007. Epub 2010 Jul 13.

引用本文的文献

1
RANKL-mediated osteoclastic subchondral bone loss at a very early stage precedes subsequent cartilage degeneration and uncoupled bone remodeling in a mouse knee osteoarthritis model.在小鼠膝骨关节炎模型中,RANKL介导的破骨细胞性软骨下骨在极早期的丢失先于随后的软骨退变和骨重塑解偶联。
J Orthop Surg Res. 2025 Mar 3;20(1):226. doi: 10.1186/s13018-025-05578-6.
2
Relationship Between the Subchondral Trabecular Bone Microstructure in the Hip Joint and Pain in Patients with Hip Osteoarthritis.髋关节软骨下小梁骨微结构与髋骨关节炎患者疼痛之间的关系
Cartilage. 2024 Dec 9:19476035241302978. doi: 10.1177/19476035241302978.
3
A RANKL-UCHL1-sCD13 negative feedback loop limits osteoclastogenesis in subchondral bone to prevent osteoarthritis progression.
RANKL-UCHL1-sCD13 负反馈回路限制软骨下骨破骨细胞生成,从而防止骨关节炎进展。
Nat Commun. 2024 Oct 10;15(1):8792. doi: 10.1038/s41467-024-53119-2.
4
Disease-modifying interactions between chronic kidney disease and osteoarthritis: a new comorbid mouse model.慢性肾脏病与骨关节炎之间的疾病修饰相互作用:一种新的合并症小鼠模型。
RMD Open. 2023 Aug;9(3). doi: 10.1136/rmdopen-2023-003109.
5
Hip osteoarthritis: A novel network analysis of subchondral trabecular bone structures.髋骨关节炎:对软骨下小梁骨结构的新型网络分析
PNAS Nexus. 2022 Nov 21;1(5):pgac258. doi: 10.1093/pnasnexus/pgac258. eCollection 2022 Nov.
6
Early Emergent and Progressive Aberrant Subchondral Bone Remodeling Coupled with Aggravated Cartilage Degeneration in Developmental Dysplasia of the Hip.早期出现且不断进展的骺软骨下骨改建伴发髋关节发育不良的软骨退变加重。
Cartilage. 2022 Apr-Jun;13(2):19476035221098165. doi: 10.1177/19476035221098165.
7
A Novel EphA4 Signaling-Based Therapeutic Strategy for Osteoarthritis in Mice.一种基于EphA4信号传导的新型小鼠骨关节炎治疗策略。
J Bone Miner Res. 2022 Apr;37(4):660-674. doi: 10.1002/jbmr.4500. Epub 2022 Jan 29.
8
Loss of mutual protection between human osteoclasts and chondrocytes in damaged joints initiates osteoclast-mediated cartilage degradation by MMPs.受损关节中破骨细胞和软骨细胞之间的相互保护丧失,启动 MMP 介导的破骨细胞性软骨降解。
Sci Rep. 2021 Nov 22;11(1):22708. doi: 10.1038/s41598-021-02246-7.
9
Betaine Attenuates Osteoarthritis by Inhibiting Osteoclastogenesis and Angiogenesis in Subchondral Bone.甜菜碱通过抑制软骨下骨破骨细胞生成和血管生成减轻骨关节炎
Front Pharmacol. 2021 Sep 29;12:723988. doi: 10.3389/fphar.2021.723988. eCollection 2021.
10
The Development of Disease-Modifying Therapies for Osteoarthritis (DMOADs): The Evidence to Date.骨关节炎(DMOAD)治疗药物的研发:现有证据。
Drug Des Devel Ther. 2021 Jul 6;15:2921-2945. doi: 10.2147/DDDT.S295224. eCollection 2021.